Margaret Kasner

2.9k total citations
76 papers, 1.1k citations indexed

About

Margaret Kasner is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Margaret Kasner has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 17 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Margaret Kasner's work include Acute Myeloid Leukemia Research (29 papers), Hematopoietic Stem Cell Transplantation (23 papers) and Multiple Myeloma Research and Treatments (11 papers). Margaret Kasner is often cited by papers focused on Acute Myeloid Leukemia Research (29 papers), Hematopoietic Stem Cell Transplantation (23 papers) and Multiple Myeloma Research and Treatments (11 papers). Margaret Kasner collaborates with scholars based in United States, Germany and United Kingdom. Margaret Kasner's co-authors include Dirk Westermann, Carsten Tschöpe, Selina M. Luger, Martin Carroll, Neil Palmisiano, Anil K. Rustgi, Wolfgang Poller, Jennifer Oliver‐Krasinski, Michael F. Crutchlow and Juxiang Yang and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Margaret Kasner

62 papers receiving 1.1k citations

Peers

Countries citing papers authored by Margaret Kasner

Since Specialization

Citations

This map shows the geographic impact of Margaret Kasner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Kasner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Kasner more than expected).

Fields of papers citing papers by Margaret Kasner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Kasner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Kasner. The network helps show where Margaret Kasner may publish in the future.

Co-authorship network of co-authors of Margaret Kasner

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Kasner. A scholar is included among the top collaborators of Margaret Kasner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Kasner. Margaret Kasner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting CD47: many misses; hopeful for a hit 2025 ·Blood ·Lindsay Wilde, Margaret Kasner	0
2	Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups 2025 ·The Lancet Haematology ·Omran Saifi, Chelsea C. Pinnix, Chris R. Kelsey, Leslie K. Ballas, Sarah A. Milgrom, Ranjana H. Advani, Margaret Kasner, Stella Flampouri, Stephanie A. Terezakis, Mark A. Sellmyer, John P. Plastaras, Bradford S. Hoppe	0
3	Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions 2023 ·Leukemia Research ·Omer Jamy, Margaret Kasner, Sarah Wall, Stacey A. Ingram, (unknown), William N. Dudley, Leah S. Dudley, (unknown), Debra Wujcik	2
4	A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia 2023 ·Cancers ·Neil Palmisiano, Grace R. Jeschke, Lindsay Wilde, Önder Alpdoğan, Matthew Carabasi, Joanne Filicko-O’Hara, Dolores Grosso, Thomas R. Klumpp, (unknown), John L. Wagner, Martin Carroll, Alexander E. Perl, Margaret Kasner	0
5	A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia 2023 ·Leukemia Research ·Lindsay Wilde, Patrizia Porazzi, Rossana Trotta, Marco De Dominici, Neil Palmisiano, (unknown), (unknown), (unknown), Bruno Calabretta, Margaret Kasner	4
6	A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous Transplantation 2022 ·Transplantation and Cellular Therapy ·Dolores Grosso, Benjamin E. Leiby, Lindsay Wilde, Matthew Carabasi, Joanne Filicko-O’Hara, (unknown), John L. Wagner, (unknown), Önder Alpdoğan, Adam Binder, Margaret Kasner, (unknown), Thomas R. Klumpp, (unknown), Neil Palmisiano, Pierluigi Porcu, Usama Gergis, Neal Flomenberg	3
7	A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemia 2022 ·Investigational New Drugs ·Margaret Kasner, Molly B. Halloran, (unknown), Ellen K. Ritchie, Gerald J. Fetterly, (unknown), David Hangauer, James E. Thompson	3
8	Co-management strategies for acute myeloid leukemia patients in the community setting 2022 ·Frontiers in Oncology ·Christopher B. Benton, Michael R. Grunwald, Hana Safah, Margaret Kasner	2
9	Caring for AML Patients During the COVID-19 Crisis: An American and Italian Experience 2020 ·Frontiers in Oncology ·Lindsay Wilde, Alessandro Isidori, (unknown), Neil Palmisiano, Margaret Kasner	6
10	Autologous Stem Cell Transplantation for Multiple Myeloma: Growth Factor Matters 2019 ·Biology of Blood and Marrow Transplantation ·Jason Chen, (unknown), Tingting Zhan, Sherilyn A. Tuazon, Neeraj Saini, (unknown), Joanne Filicko-O’Hara, Thomas R. Klumpp, Margaret Kasner, Matthew Carabasi, Pierluigi Porcu, John L. Wagner	6
11	Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition 2018 ·Investigational New Drugs ·Margaret Kasner, Rosemarie Mick, Grace R. Jeschke, Matthew Carabasi, Joanne Filicko-O’Hara, Neal Flomenberg, Noelle V. Frey, Elizabeth O. Hexner, Selina M. Luger, Alison W. Loren, James K. Mangan, John L. Wagner, Mark A. Weiss, Martin Carroll, Alexander E. Perl	17
12	ABO Blood Type and the Risk of Cardovascular Events: An Analysis of Framingham Data and Meta-Analysis 2017 ·Blood ·Margaret Kasner, Barbara A. Konkle, Mark Cary, Stephen Kimmel	1
13	The Presence of Recipient CMV Immunodominant Human Leukocyte Antigen (HLA) Alleles Affect Outcomes after Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT) 2017 ·Blood ·Dolores Grosso, Önder Alpdoğan, (unknown), Joanne Filicko-O’Hara, Sameh Gaballa, Margaret Kasner, Thomas R. Klumpp, Ubaldo Martinez‐Outschoorn, (unknown), Neil Palmisiano, John L. Wagner, Pierluigi Porcu, Neal Flomenberg	1
14	A Phase II Study of Azacitidine and Sirolimus for the Treatment of Acute Myeloid Leukemia (AML) Refractory to or Not Eligible for Intensive Chemotherapy or High Risk Myelodysplastic Syndrome (MDS) 2017 ·Blood ·Neil Palmisiano, Grace R. Jeschke, Lindsay Wilde, Benjamin E. Leiby, Önder Alpdoğan, (unknown), Joanne Filicko-O’Hara, Sameh Gaballa, Dolores Grosso, Thomas R. Klumpp, (unknown), John L. Wagner, Martin Carroll, Pierluigi Porcu, Neal Flomenberg, Alexander E. Perl, Margaret Kasner	1
15	Disseminated Nocardia cyriacigeorgia causing pancreatitis in a haploidentical stem cell transplant recipient 2017 ·IDCases ·Jason Chen, (unknown), Joanne Filicko-O’Hara, Margaret Kasner, Phyllis Flomenberg	1
16	Differences in Allogeneic Product T-Cell Subsets According to Donor Age: Associations with Immune Reconstitution and Acute Graft Versus Host Disease (aGVHD) in Haploidentical (HI) Hematopoietic Stem Cell Transplantation (HSCT) 2017 ·Blood ·Jason Chen, (unknown), John L. Wagner, Michael Sun, Önder Alpdoğan, Matthew Carabasi, Joanne Filicko-O’Hara, Sameh Gaballa, Margaret Kasner, Thomas R. Klumpp, Neil Palmisiano, Ubaldo Martinez‐Outschoorn, Pierluigi Porcu, Neal Flomenberg, Dolores Grosso	1
17	A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation 2015 ·Biology of Blood and Marrow Transplantation ·Sameh Gaballa, Neil Palmisiano, Önder Alpdoğan, Matthew Carabasi, Joanne Filicko-O’Hara, Margaret Kasner, Walter K. Kraft, Benjamin E. Leiby, Ubaldo Martinez‐Outschoorn, (unknown), Barbara Pro, (unknown), Manish Sharma, John L. Wagner, Mark A. Weiss, Neal Flomenberg, Dolores Grosso	21
18	Single-Cell Pharmacodynamic Monitoring of S6 Ribosomal Protein Phosphorylation in AML Blasts during a Clinical Trial Combining the mTOR Inhibitor Sirolimus and Intensive Chemotherapy 2011 ·Clinical Cancer Research ·Alexander E. Perl, Margaret Kasner, (unknown), Selina M. Luger, Martin Carroll	44
19	Trisomy 8 in an allogeneic stem cell transplant recipient representative of a donor‐derived constitutional abnormality 2008 ·American Journal of Hematology ·Noelle V. Frey, (unknown), Peter C. Nowell̀, (unknown), (unknown), Margaret Kasner, Steven C. Goldstein, Alison W. Loren, Edward A. Stadtmauer, Selina M. Luger, Elizabeth O. Hexner, (unknown), David L. Porter	9
20	Increased cerebral blood flow after leukapheresis for acute myelogenous leukemia 2007 ·American Journal of Hematology ·Margaret Kasner, Adrienne M. Laury, Scott E. Kasner, Martin Carroll, Selina M. Luger	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact